Rockefeller Capital Management
TMCI icon

Rockefeller Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Rockefeller Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3K Hold
8,360
– – ﹤0.01% 3542
2026
Q1 		$11.2K Hold
8,360
– – ﹤0.01% 3949
2025
Q4 		$20.5K Hold
8,360
– – ﹤0.01% 3508
2025
Q3 		$56.1K Buy
+8,360
New +$54.6K ﹤0.01% 2855
2023
Q3 		– Sell
-11,599
Closed -$204K – 1806
2023
Q2 		$204K Sell
11,599
-970
-8% -$25K ﹤0.01% 1643
2023
Q1 		$316K Buy
12,569
+11,569
+1,157% +$272K ﹤0.01% 1553
2022
Q4 		$22K Hold
1,000
– – ﹤0.01% 2773
2022
Q3 		$22K Buy
+1,000
New +$19.3K ﹤0.01% 2733
2021
Q4 		– Sell
-53
Closed -$1K – 3988
2021
Q3 		$1K Buy
+53
New +$1.46K ﹤0.01% 3623

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rockefeller Capital Management's TMCI Position: Q2 2026 in Review

Rockefeller Capital Management held its Treace Medical Concepts (TMCI) position steady in Q2 2026 at 8,360 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

Rockefeller Capital Management first reported a position in TMCI in Q3 2021 and has held it in 9 quarters since. The position peaked at $316K in Q1 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Rockefeller Capital Management held 8,360 shares of Treace Medical Concepts worth $33.3K as of Q2 2026.
  • Rockefeller Capital Management left its Treace Medical Concepts share count unchanged in Q2 2026.
  • Treace Medical Concepts made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3542 holding.
  • Rockefeller Capital Management first reported a position in Treace Medical Concepts in Q3 2021 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Treace Medical Concepts position peaked at $316K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.